D'AVANZO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.139
EU - Europa 167
AS - Asia 51
Totale 1.357
Nazione #
US - Stati Uniti d'America 1.139
SE - Svezia 55
CN - Cina 48
IT - Italia 35
FI - Finlandia 21
DE - Germania 16
GB - Regno Unito 16
UA - Ucraina 10
IE - Irlanda 9
IN - India 3
RU - Federazione Russa 2
ES - Italia 1
FR - Francia 1
HU - Ungheria 1
Totale 1.357
Città #
Fairfield 168
Houston 133
Ann Arbor 109
Woodbridge 109
Chandler 99
Ashburn 82
Cambridge 74
Wilmington 70
Seattle 57
Jacksonville 24
Des Moines 22
Padova 20
Medford 17
New York 17
Princeton 17
San Diego 17
Beijing 13
Boardman 10
Dublin 9
Helsinki 9
Nanjing 7
Cagliari 6
Munich 6
Falls Church 4
Auburn Hills 3
Changsha 2
Kharkiv 2
Milan 2
Nanchang 2
Neustadt am Ruebenberge 2
Phoenix 2
Vicenza 2
Chongqing 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hefei 1
Huzhou 1
Indiana 1
Jinhua 1
Kilburn 1
Lanzhou 1
Lappeenranta 1
London 1
Los Angeles 1
Norwalk 1
Perris 1
Rockville 1
Rome 1
San Jose 1
Sant'elena 1
Shanghai 1
Shenyang 1
Tappahannock 1
Teaneck 1
Tianjin 1
Xi'an 1
Zhengzhou 1
Totale 1.142
Nome #
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 148
QueryOR: a comprehensive web platform for genetic variant analysis and prioritization 132
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 129
Glial degeneration with oxidative damage drives neuronal demise in MPSII disease 112
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders 102
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 99
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 94
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 75
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years 75
The ethical framework for performing research with rare inherited neurometabolic disease patients 66
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders Inherited metabolic diseases 64
Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases. 62
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 62
Analysis of Hunter Syndrome by RNA-Sequencing 51
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study 38
Setup and Validation of a Targeted Next-Generation Sequencing Approach for the Diagnosis of Lysosomal Storage Disorders 36
Mucopolysaccharidosis type II: One hundred years of research, diagnosis, and treatment 26
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 15
Totale 1.386
Categoria #
all - tutte 5.194
article - articoli 4.936
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201959 0 0 0 0 0 0 0 0 0 0 35 24
2019/2020238 25 11 3 19 24 19 21 32 24 28 24 8
2020/2021233 12 8 4 7 13 12 6 16 29 105 12 9
2021/2022280 16 21 20 29 41 20 15 25 24 7 17 45
2022/2023209 27 15 5 30 30 40 3 14 26 5 11 3
2023/2024103 4 19 10 12 9 27 12 7 0 3 0 0
Totale 1.386